Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo
Webinar :Join an expert panel for a webinar on Smart investments for a secure retirement January 28, 2021. Register now!
you are here: HomeNewsIndia

Tobacco use accelerates transmission of COVID-19: Health Ministry

In its document 'COVID-19 Pandemic and Tobacco Use in India', the ministry said experts have confirmed that smokers are more likely to develop severe symptoms or die from COVID-19, as it primarily attacks the lungs and warned against use of any such products.

July 29, 2020 / 01:16 PM IST

Smokers are likely to be more vulnerable to COVID-19 as smoking increases possibility of transmission of virus from hand to mouth, the Union Health Ministry has said, warning that use of tobacco products can increase severity of respiratory infections and make people susceptible to coronavirus.

In its document 'COVID-19 Pandemic and Tobacco Use in India', the ministry said experts have confirmed that smokers are more likely to develop severe symptoms or die from COVID-19, as it primarily attacks the lungs and warned against use of any such products.

Smokers, it warned, are likely to be more vulnerable to COVID-19 as the act of smoking means that fingers (and possibly contaminated cigarettes) are in contact with lips which increases the possibility of transmission of virus from hand to mouth.

"Further smoking products such as water pipes or hookah often involve the sharing of mouth-pieces and hoses, which could facilitate the transmission of COVID-19 in communal and social settings," the ministry said.

Tobacco use is a major risk factor for the four main Non-communicable Diseases (NCDs) — cardiovascular disease, cancer, chronic lung disease and diabetes, which puts people with these conditions at higher risk for developing severe illness when affected by COVID-19. NCDs are estimated to account for 63 percent of all deaths in India and these are expected to rise further.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The chemicals in tobacco smoke suppress the activity of different types of immune cells that are involved in general and targeted immune responses.

"Smoking impairs lung function, thereby reducing the immunity and making it harder for the body to fight off various diseases. Smoking, e-cigarettes, smokeless tobacco, pan masala and the like products use can increase risk and severity of pulmonary infections because of damage to upper airways and a decrease in pulmonary immune function," it said.

Evidence from countries reporting coronavirus infection related fatalities has highlighted that the people with pre-existing non-communicable diseases (NCDs) are more susceptible to becoming severely ill with COVID-19, the document stated.

Tobacco use poses a significant risk by accelerating the transmission of COVID-19 because the virus spreads primarily through droplets of saliva or discharge from the nose when an infected person coughs or sneezes.

Chewing tobacco products (khaini, gutkha, paan, zarda) increases the urge to spit. Spitting in public places increases health risks especially those of spreading the infectious and contagious diseases like, COVID-19, tuberculosis, swine flu, encephalitis, etc, the ministry underlined.

"The Ministry of Health and Family Welfare warns against the use of any tobacco products," it said, adding within 12 hours of quitting, the carbon monoxide level in the bloodstream drops to normal.

Within 2-12 weeks, circulation improves and lung function increases. After 1-9 months, coughing and shortness of breath decreases, it said.

Follow our full coverage of the coronavirus pandemic here.
PTI
first published: Jul 29, 2020 12:50 pm

stay updated

Get Daily News on your Browser
Sections